Effect of alpha-inhibitors on blood glucose and insulin levels.
Laube
H
H
Department of Internal Medicine, University of Giessen, FRG.
Federlin
K
K
Hillebrand
I
I
D017485:1-Deoxynojirimycin / Q000031:analogs & derivatives; D020909:Acarbose; D000368:Aged; D001786:Blood Glucose / Q000378:metabolism*; D003920:Diabetes Mellitus / Q000097:blood* / Q000188:drug therapy; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000188:drug therapy; D004311:Double-Blind Method; D005944:Glucosamine / Q000031:analogs & derivatives* / Q000494:pharmacology; D065089:Glycoside Hydrolase Inhibitors; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D050112:Imino Pyranoses; D007328:Insulin / Q000097:blood*; D008875:Middle Aged; D009765:Obesity; D012016:Reference Values; D014312:Trisaccharides / Q000494:pharmacology / Q000627:therapeutic use*
D001786:Blood Glucose; D065089:Glycoside Hydrolase Inhibitors; D007004:Hypoglycemic Agents; D050112:Imino Pyranoses; D007328:Insulin; D014312:Trisaccharides; C045621:miglitol; D017485:1-Deoxynojirimycin; D005944:Glucosamine; D020909:Acarbose